321 related articles for article (PubMed ID: 34807420)
1. Pathophysiology and Pathogenesis of Marfan Syndrome.
Zeigler SM; Sloan B; Jones JA
Adv Exp Med Biol; 2021; 1348():185-206. PubMed ID: 34807420
[TBL] [Abstract][Full Text] [Related]
2. Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-β Signaling.
Wheeler JB; Ikonomidis JS; Jones JA
Adv Exp Med Biol; 2021; 1348():161-184. PubMed ID: 34807419
[TBL] [Abstract][Full Text] [Related]
3. Marfan syndrome revisited: From genetics to the clinic.
Coelho SG; Almeida AG
Rev Port Cardiol (Engl Ed); 2020 Apr; 39(4):215-226. PubMed ID: 32439107
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
De Backer J
Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of aortopathy in Marfan syndrome and related diseases.
Jones JA; Ikonomidis JS
Curr Cardiol Rep; 2010 Mar; 12(2):99-107. PubMed ID: 20425163
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes.
Cook JR; Carta L; Galatioto J; Ramirez F
Clin Genet; 2015; 87(1):11-20. PubMed ID: 24867163
[TBL] [Abstract][Full Text] [Related]
7. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
8. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1.
Zangwill SD; Brown MD; Bryke CR; Cava JR; Segura AD
Congenit Heart Dis; 2006 Sep; 1(5):229-32. PubMed ID: 18377530
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and Management of Cardiovascular Manifestations in Marfan and Loeys-Dietz Syndromes.
Takeda N; Yagi H; Hara H; Fujiwara T; Fujita D; Nawata K; Inuzuka R; Taniguchi Y; Harada M; Toko H; Akazawa H; Komuro I
Int Heart J; 2016 May; 57(3):271-7. PubMed ID: 27181042
[TBL] [Abstract][Full Text] [Related]
10. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
[TBL] [Abstract][Full Text] [Related]
12. Marfan syndrome: from gene to therapy.
Bolar N; Van Laer L; Loeys BL
Curr Opin Pediatr; 2012 Aug; 24(4):498-504. PubMed ID: 22705998
[TBL] [Abstract][Full Text] [Related]
13. The molecular genetics of Marfan syndrome and related disorders.
Robinson PN; Arteaga-Solis E; Baldock C; Collod-Béroud G; Booms P; De Paepe A; Dietz HC; Guo G; Handford PA; Judge DP; Kielty CM; Loeys B; Milewicz DM; Ney A; Ramirez F; Reinhardt DP; Tiedemann K; Whiteman P; Godfrey M
J Med Genet; 2006 Oct; 43(10):769-87. PubMed ID: 16571647
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?
Matt P; Habashi J; Carrel T; Cameron DE; Van Eyk JE; Dietz HC
J Thorac Cardiovasc Surg; 2008 Feb; 135(2):389-94. PubMed ID: 18242274
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders.
Mizuguchi T; Matsumoto N
J Hum Genet; 2007; 52(1):1-12. PubMed ID: 17061023
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and Japanese clinical characteristics in Marfan syndrome.
Fujita D; Takeda N; Imai Y; Inuzuka R; Komuro I; Hirata Y
Pediatr Int; 2014 Aug; 56(4):484-91. PubMed ID: 24931486
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.
Wheeler JB; Ikonomidis JS; Jones JA
Adv Exp Med Biol; 2014; 802():107-27. PubMed ID: 24443024
[TBL] [Abstract][Full Text] [Related]
18. The differences in surgical long-term outcomes between Marfan syndrome and Loeys-Dietz syndrome.
Seike Y; Matsuda H; Inoue Y; Sasaki H; Morisaki H; Morisaki T; Kobayashi J
J Thorac Cardiovasc Surg; 2022 Jul; 164(1):16-25.e2. PubMed ID: 32891455
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
20. Marfan syndrome: An eyesight of syndrome.
Kumar A; Agarwal S
Meta Gene; 2014 Dec; 2():96-105. PubMed ID: 25606393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
